BLOG

Key Research Findings 2025 multicenter trial of 1,106 sepsis patients showed 28-day mortality reduction with thymosin alpha 1 treatment Mechanism targets CD4+ T cell enhancement and CD4+/CD8+ ratio optimization for superior immune function Clinical evidence...

Key Research Findings Recent 2025 studies show Thymosin Beta-4 promotes neuroprotection through BDNF upregulation and TrkB receptor enhancement TB500 mechanisms involve direct ROCK1 protein modulation and SLC7A11 pathway regulation for cellular protection Clinical...

Key Research Findings Clinical trials demonstrate 25% reduction in visceral adipose tissue with tesamorelin treatment over 26 weeks Growth hormone-releasing hormone analog shows neuroprotective effects in HIV-associated cognitive impairment studies Tesamorelin...

Key Research Findings SS-31 demonstrates 35% improvement in ATP production and 40% reduction in ROS levels in aged bone marrow stem cells Phospholipid scramblase 3 (PLSCR3) identified as essential mediator of SS-31's mitochondrial protective effects Clinical trials...

SLU-PP-332 demonstrates significant metabolic improvements with 25 lb fat mass reduction in diet-induced obesity models Functions as pan-ERR agonist with highest potency for ERRα activation and exercise mimetic properties Clinical research shows improved ejection...

Key Research Findings Semax demonstrates significant neuroprotective effects through μ-opioid receptor modulation and USP18 regulation in spinal cord injury models ACTH(4-7)PGP structure enables enhanced BDNF production and TrkB receptor sensitivity in hippocampal...

Key Research Findings Selank demonstrates 39.6% reduction in morphine withdrawal syndrome severity in controlled studies This anxiolytic peptide operates through GABA receptor modulation without dependency risk Clinical trials show significant stress response...

Key Research Findings Phase 2 trials demonstrate up to 24.2% mean weight loss after 48 weeks in obesity research Triple mechanism targets GLP-1, GIP, and glucagon receptors simultaneously for enhanced metabolic effects 82% reduction in hepatic steatosis observed in...

Key Research Findings PT-141 (bremelanotide) demonstrates significant efficacy in treating hypoactive sexual desire disorder through melanocortin 3 and 4 receptor activation Clinical trials show improved Female Sexual Function Index scores with nasal spray...

Key Research Findings PNC-27 demonstrates selective cytotoxicity with IC₅₀ values of 12.4 μM against cervical cancer cells while sparing normal cells Unique mechanism targets HDM-2 proteins exclusively expressed in cancer cell membranes, not normal cells Laboratory...